Psychiatry · Friendswood, TX
NPI
1932549250
Since 2013
Specialty
Psychiatry
Code 2084P0800X
Group practices
7
Medicare group memberships
Hospitals
0
Hospital affiliations
104 Whispering Pines Ave
Friendswood, TX, 77546
Phone (713) 429-5325
Groups this clinician bills Medicare through
Medicare paid, 2024
$248K
3,107 services
Medicare patients, 2024
625
Average age 68
Drug cost, 2024
$1.3M
11,559 prescriptions
Company payments, 2025
$486
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed N Zaidi was code 99232 (hospital e&m - subsequent), 987 times for 252 patients. In total Syed N Zaidi billed 3,107 services in 12 codes, and Medicare paid $248K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-06-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 987 | 252 | $62.77 | $62K |
| 99232 Hospital E&M - Subsequent | Office | 571 | 164 | $62.65 | $36K |
| 99233 Hospital E&M - Subsequent | Facility | 524 | 155 | $94.43 | $49K |
| 99223 Hospital E&M - Initial | Office | 252 | 235 | $134.52 | $34K |
| 99223 Hospital E&M - Initial | Facility | 230 | 218 | $136.08 | $31K |
| 99213 Office E&M - Established | Office | 123 | 34 | $52.44 | $6,450 |
| 99214 Office E&M - Established | Office | 122 | 58 | $77.51 | $9,456 |
| 99309 SNF E&M | Office | 83 | 76 | $29.22 | $2,425 |
| 99233 Hospital E&M - Subsequent | Office | 58 | 45 | $94.65 | $5,490 |
| 99239 Hospital Discharge Management | Facility | 53 | 53 | $90.95 | $4,820 |
| 99239 Hospital Discharge Management | Office | 39 | 35 | $90.89 | $3,545 |
| 99309 SNF E&M | Facility | 20 | 20 | $45.36 | $907 |
| 99308 SNF E&M | Office | 17 | 17 | $26.22 | $446 |
By year: 2022 $181K for 2,818 services; 2023 $309K for 3,985 services; 2024 $248K for 3,107 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed N Zaidi prescribed most often to Medicare patients was Trazodone Hcl, with 921 prescriptions and refills. In total Syed N Zaidi wrote 11,559 Medicare prescriptions that cost $1.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Trazodone Hcl Generic | 921 | 977 | 535 | $12K |
| Divalproex Sodium Generic | 573 | 604 | 346 | $21K |
| Risperidone Generic | 490 | 534 | 307 | $7,078 |
| Donepezil Hcl Generic | 471 | 529 | 323 | $4,688 |
| Aripiprazole Generic | 422 | 453 | 289 | $20K |
| Memantine Hcl Generic | 417 | 430 | 292 | $14K |
| Fluoxetine Hcl Generic | 401 | 431 | 272 | $3,738 |
| Hydroxyzine Pamoate Generic | 377 | 383 | 291 | $7,358 |
| Quetiapine Fumarate Generic | 303 | 351 | 99 | $6,298 |
| Atorvastatin Calcium Generic | 301 | 303 | 265 | $2,761 |
| Buspirone Hcl Generic | 253 | 264 | 113 | $3,349 |
| Mirtazapine Generic | 252 | 280 | 173 | $4,149 |
| Gabapentin Generic | 216 | 255 | 135 | $3,106 |
| Olanzapine Generic | 199 | 221 | 61 | $6,441 |
| Sertraline Hcl Generic | 193 | 235 | 111 | $1,382 |
Brand drugs: - claims; generic drugs: 10,887 claims; opioid claims: 31.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed N Zaidi $486 ($486 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abiomed with $186.
| Company | Payments | Amount |
|---|---|---|
| Abiomed JNJ | 1 | $186 |
| UCB, Inc. UCB.BR | 2 | $54.86 |
| ACADIA Pharmaceuticals Inc ACAD | 2 | $43.99 |
| Alkermes, Inc. ALKS | 2 | $36.87 |
| Otsuka America Pharmaceutical, Inc. 4578.T | 2 | $32.45 |
| E.R. Squibb & Sons, L.L.C. BMY | 2 | $32.15 |
| Neurocrine BioSciences, Inc. NBIX | 1 | $26.5 |
| Teva Pharmaceuticals USA, Inc. TEVA | 1 | $26.31 |
| SK Life Science, Inc. | 1 | $25.87 |
| Luye Pharma (USA) Ltd. 2186.HK | 1 | $20.81 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.